BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32098798)

  • 1. Detection of Barrett's oesophagus through exhaled breath using an electronic nose device.
    Peters Y; Schrauwen RWM; Tan AC; Bogers SK; de Jong B; Siersema PD
    Gut; 2020 Jul; 69(7):1169-1172. PubMed ID: 32098798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath Testing for Barrett's Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device.
    Chan DK; Zakko L; Visrodia KH; Leggett CL; Lutzke LS; Clemens MA; Allen JD; Anderson MA; Wang KK
    Gastroenterology; 2017 Jan; 152(1):24-26. PubMed ID: 27825962
    [No Abstract]   [Full Text] [Related]  

  • 3. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
    Royston C; Caygill C; Charlett A; Bardhan KD
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
    Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
    Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
    Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
    Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm?
    Rajendra S
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):65-75. PubMed ID: 25743457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hiatal hernia and Barrett's oesophagus impact on symptoms occurrence and complications.
    Al-Tashi M; Rejchrt S; Kopácová M; Tycová V; Siroký M; Repák R; Tachecí I; Douda T; Cyrany J; Fejfar T; Hůlek P; Bukac J; Bures J
    Cas Lek Cesk; 2008; 147(11):564-8. PubMed ID: 19097360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
    McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
    IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.